970 resultados para Pharmaceutical Sciences (111504)

New drugs being developed for the treatment of tuberculosis

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Photochemical and antioxidant responses in the leaves of xerophyta viscosa Baker and digitaria sanguinalis L. under water deficit

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Does rosiglitazone increase cardiovascular outcomes?

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Is fingolimod an advancement in the treatment of multiple sclerosis?

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Rosiglitazone: rosy news for a thiazolidinedione

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Ximelagatran - recent comparisons with warfarin

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Calmodulin kinase II as a target for inhibition in cardiac disease

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Recent evidence of sustained benefit with exenatide in Type 2 diabetes

Relevância:

80.00% 80.00%

Publicador:

Veja mais

BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Is exenatide advancing the treatment of Type 2 diabetes?

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Bradykinin B2 receptors - a target in diabetic nephropathy

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Pregabalin or morphine and gabapentin for neuropathic pain

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia?

Relevância:

80.00% 80.00%

Publicador:

Veja mais

The effects of both noradrenaline and CGP12177, mediated through human Beta1-adrenoceptors, are reduced by PDE3 in human atrium but PDE4 in CHO cells

Relevância:

80.00% 80.00%

Publicador:

Veja mais

Pegaptanib: the first antiangiogenic agent approved for neovascular macular degeneration

Relevância:

80.00% 80.00%

Publicador:

Veja mais